Financhill
Back

Merck & Stock Predictions

Merck & Stock Forecast

  • Over the next 52 weeks, Merck & has on average historically risen by 10.9% based on the past 52 years of stock performance.
  • Merck & has risen higher in 33 of those 52 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.46%
  • Is Merck & Stock Undervalued?
    The current Merck & [MRK] share price is $101.88. The Score for MRK is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • MRK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Merck & Stock Go Up Next Year?

  • Over the next 52 weeks, Merck & has on average historically risen by 10.9% based on the past 52 years of stock performance.

Merck & Stock Rating

Sell
23
Merck & (MRK) is a Sell

Is Merck & overpriced?

  • Merck & has risen higher in 33 of those 52 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.46%

Merck & Stock Price History

Is MRK stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRK is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
S&P500
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
merck.com

52-Week Data

52-Week High:
134.63
52-Week Low:
98.60

Prediction Charts

Market Cap:
258.25B
Price in USD:
101.88
Volume:
9.22M
Beta:
0.64

Technical Analysis

SMA50:
112.39
SMA100:
117.71
SMA200:
122.13
52-Wk Change:
-0.94%

Stock Predictions

  • Is Merck & stock public?
    Yes, Merck & is a publicly traded company.
  • What is the Merck & stock quote today?
    The Merck & stock price is 101.88 USD today.
  • How to buy Merck & stock online?
    You can buy Merck & shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-14 109.43 109.69 110.07 108.68
Oct-15 109.96 111.53 111.58 109.89
Oct-16 111.00 110.42 111.20 109.02
Oct-18 109.90 108.70 109.92 108.56
Oct-21 109.08 106.34 109.17 106.18
Oct-22 105.91 106.64 106.90 105.71
Oct-23 106.74 106.38 107.36 106.20
Oct-24 106.05 105.88 106.62 105.26
Oct-25 106.49 103.98 106.49 103.86
Oct-28 104.60 104.23 105.00 103.93
Oct-29 104.32 103.73 105.11 103.70
Oct-30 103.46 104.83 105.00 102.90
Oct-31 100.93 102.32 103.23 98.60
Nov-1 101.78 101.88 102.72 101.21

Merck & Earnings

Merck & Earnings Report: Per Share Merck & Earnings Q1 Q2 Q3 and Q4 last year and next year.

Merck & Forecast Revenue Growth

Merck & Stock Analysis: Historical quarterly revenues per share for Merck & and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.98 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.47 per share, and an increase next year of $1.73 per share.

* Merck & stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.